Please provide your email address to receive an email when new articles are posted on . Targeted human albumin solution increased serum sodium in hospitalized patients with cirrhosis and hyponatremia, ...
Daily infusions of albumin provide no significant health benefit to patients hospitalised with advanced liver disease, over and above 'standard care', finds a large-scale multicentre trial led by UCL ...
GLOMERULAR filtration rate and renal plasma flow may be sharply reduced in patients with advanced cirrhosis. 1–4 Reduction of glomerular filtration and deficient urine volume in these patients is ...
Purpose: The technical issues surrounding the use of albumin in parenteral nutrient (PN) solutions are reviewed. Summary: Five criteria have been suggested to determine which compounds are optimal for ...
BARCELONA, Spain, Nov. 4, 2021 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, today announced the launch of its latest albumin ...
Researchers also found an improvement in specialized blood markers focusing on inflammation, endothelial dysfunction, and albumin function in patients receiving weekly albumin injection. Among ...
Phase II trial of high-dose interleukin-2 (IL-2) with priming and concomitant sargramostim (GM-CSF) in patients with advanced melanoma. Results: Ten patients have been treated with the OBL one-hour ...
German scientists have identified a serious and previously misunderstood contaminant that brings the safety and efficacy of intravenous treatments into question. In a report published in the September ...
Five criteria to determine which compounds are optimal for addition to PN solutions have been suggested: (1) stable dosage regimen over 24 hours, (2) pharmacokinetic profile supporting a 24-hour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results